On September 18, 2025, IPURE will make its debut at the Dortmund Exhibition Center in Germany, joining global partners for the annual InterTabac & InterSupply trade fair. As an innovator in the field of e-liquid manufacturing, we are bringing you an immersive experience that combines smokeless technology demonstrations, flavor tastings, and customized OEM/ODM services.

As we look towards 2025, the e-liquid industry is poised for a flavor revolution, and IPURE, a leading e liquid manufacturer, is at the forefront of this exciting transformation.

In the rapidly evolving world of vaping, IPURE has emerged as a trailblazer, setting new benchmarks for quality and innovation in the e-liquid industry.

U.S. FDA Authorized E-Cigarette List Explained: 39 Legal Products and Industry Insights The U.S. Food and Drug Administration (FDA), under the Family Smoking Prevention and Tobacco Control Act (established in 2009), created the PMTA (Premarket Tobacco Product Application) framework. Through this scientific review system, FDA evaluates whether e-cigarettes provide harm reduction value for adult smokers while minimizing risks to non-smokers, particularly youth, in order to determine if a product is “Appropriate for the Protection of Public Health” (APPH). Only products that pass the PMTA review with sufficient scientific evidence are legally permitted to be marketed in the United States.

Guernsey Proposes Vaping Juice Tax: A Turning Point for Industry Growth The Guernsey Policy & Resources Committee (P&R) has recently proposed a tax on e-liquid in the island’s 2026 budget—charging £2 per 10 ml (approximately $2.6 USD). The budget is slated for release on October 7, with parliamentary debate scheduled for November

In the rapidly evolving world of vaping, IPURE has emerged as a frontrunner in the e-liquid wholesale industry.

​In the fast-evolving world of vaping, IPURE has established itself as a leading e liquid manufacturer, offering innovative solutions for businesses seeking to make their mark in the industry.

KT&G Releases 2025 Financial Report: Overseas Business Thrives, Net Profit Faces Challenges Korea Tobacco & Ginseng Corporation (KT&G) has released its financial results for the second quarter and first half of 2025, revealing strong growth across multiple business segments. However, despite rising revenue, net profit faced pressure due to increased costs and intensifying market competition.